GB2177914B - A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia - Google Patents

A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia

Info

Publication number
GB2177914B
GB2177914B GB8613320A GB8613320A GB2177914B GB 2177914 B GB2177914 B GB 2177914B GB 8613320 A GB8613320 A GB 8613320A GB 8613320 A GB8613320 A GB 8613320A GB 2177914 B GB2177914 B GB 2177914B
Authority
GB
United Kingdom
Prior art keywords
anemia
treatment
pharmaceutical composition
active agent
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8613320A
Other languages
English (en)
Other versions
GB2177914A (en
GB8613320D0 (en
Inventor
Naoto Shimoda
Kazuo Igusa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of GB8613320D0 publication Critical patent/GB8613320D0/en
Publication of GB2177914A publication Critical patent/GB2177914A/en
Application granted granted Critical
Publication of GB2177914B publication Critical patent/GB2177914B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB8613320A 1985-06-04 1986-06-02 A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia Expired GB2177914B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12112685 1985-06-04

Publications (3)

Publication Number Publication Date
GB8613320D0 GB8613320D0 (en) 1986-07-09
GB2177914A GB2177914A (en) 1987-02-04
GB2177914B true GB2177914B (en) 1989-10-25

Family

ID=14803522

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8613320A Expired GB2177914B (en) 1985-06-04 1986-06-02 A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia

Country Status (4)

Country Link
JP (1) JPH0676336B2 (fr)
DE (1) DE3618561A1 (fr)
FR (1) FR2587216B1 (fr)
GB (1) GB2177914B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601923A1 (de) * 1986-01-23 1987-07-30 Behringwerke Ag Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung
NO881507D0 (no) * 1987-04-10 1988-04-07 Ortho Pharma Corp Fremgangsmaate for forhoeyning av hematokritnivaaet til et normalt pattedyr.
JP3249147B2 (ja) * 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
EP0459516A1 (fr) * 1990-06-01 1991-12-04 Kirin-Amgen, Inc. Formes d'administration orale de protéines biologiquement actifs
KR100263943B1 (ko) * 1991-02-08 2000-08-16 마아크 짐머 조혈 개선을 위한 옥시푸린 뉴클레오시드 및 그의 동종체 및 그의 아실 유도체
DE4126984A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, gut vertraeglichen arzneimitteln fuer infusions- oder injektionszwecke
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
GB9506051D0 (en) * 1995-03-24 1995-05-10 Univ Singapore Gene expression
WO2004084859A2 (fr) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Formulations nasales de calcitonine contenant du chlorobutanol
CU23317A1 (es) * 2005-07-22 2008-10-22 Ct De Investigacia N Y Desarro Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central
SG179131A1 (en) * 2009-09-15 2012-04-27 Kaneka Corp Modified erythropoietin to which water-soluble long-chain molecule is added
JP5672554B2 (ja) * 2010-08-19 2015-02-18 Ｊｃｒファーマ株式会社 皮下又は経皮吸収用組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2135676A (en) * 1983-02-21 1984-09-05 Snow Brand Milk Products Co Ltd Erythropoietin by antibody affinity chromatography
GB2171304A (en) * 1985-02-06 1986-08-28 Chugai Pharmaceutical Co Ltd Compositions containing erythropoietin
GB2171303A (en) * 1985-02-06 1986-08-28 Chugai Pharmaceutical Co Ltd Anemia treatment compositions containing erythropoietin
EP0148605B1 (fr) * 1983-12-13 1990-07-25 Kirin-Amgen, Inc. Production d'érythropoiétine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
JPS57149228A (en) * 1981-03-11 1982-09-14 Ajinomoto Co Inc Novel erythropoietin and its preparation
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPS61126014A (ja) * 1984-11-22 1986-06-13 Teijin Ltd 経鼻投与用水性液剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2135676A (en) * 1983-02-21 1984-09-05 Snow Brand Milk Products Co Ltd Erythropoietin by antibody affinity chromatography
EP0148605B1 (fr) * 1983-12-13 1990-07-25 Kirin-Amgen, Inc. Production d'érythropoiétine
GB2171304A (en) * 1985-02-06 1986-08-28 Chugai Pharmaceutical Co Ltd Compositions containing erythropoietin
GB2171303A (en) * 1985-02-06 1986-08-28 Chugai Pharmaceutical Co Ltd Anemia treatment compositions containing erythropoietin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Merck Index-10th Edition, page 533 *

Also Published As

Publication number Publication date
GB2177914A (en) 1987-02-04
GB8613320D0 (en) 1986-07-09
DE3618561A1 (de) 1987-01-02
JPS6289627A (ja) 1987-04-24
JPH0676336B2 (ja) 1994-09-28
FR2587216A1 (fr) 1987-03-20
FR2587216B1 (fr) 1989-09-22

Similar Documents

Publication Publication Date Title
GB2184016B (en) Therapeutic device for the administration of medicaments
GB8609219D0 (en) Transdermal delivery of drugs
GB2178965B (en) Devices for administering medicaments to patients
GB2199031B (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
HUT41418A (en) Process for producing pharmaceutical compositions containing anticoagulator polipeptides and process for producing the active agents
NZ216029A (en) Device for transdermal delivery of nitroglycerine and pharmaceutical composition
EP0200508A3 (en) Adhesive oral bandages and oral pharmaceutical preparations
GB2181346B (en) Pharmaceutical compositions and medical uses of dioxopiperidine derivatives
HUT41800A (en) Process for producing new beta-lactame antibiotica and pharmaceutical compositions containing them as active agents
GB2177914B (en) A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia
GR861422B (en) Nasal pharmaceutical compositions
IL77083A (en) Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof
GB2192134B (en) Transdermal delivery of drugs
EP0279887A3 (en) Carnitine directed pharmaceutical agents and their use for the manufacture of a medicament for the treatment of muscle disorder
IL78843A (en) Salts of n-acyl-thiazolidine-4-carboxylic acid with 6-piperidino-2-4-diaminopyrimidine-3-oxide and pharmaceutical and cosmetic compositions containing them
GR3030150T3 (en) Use of Human Interferon-Beta 2A for the preparation of medicaments
ZA862416B (en) Composition for delivery of orally administered drugs and other substances
IL79163A0 (en) 1,8-bridged 4-quinolone-3-carboxylic acids,their preparation,medicaments containing them and their use for the preparation of medicaments
HUT41757A (en) Process for producing pharmaceutical compositions containing e-desmethyl-mevalonic acid derivatives and process for producing the active agents
PT83870A (en) Process for the preparation of n-(pyrrol-1-yl)pyridinamides and pharmaceutical compounds containing them
IL75970A0 (en) Pharmaceutical preparations for the treatment of blood flow disturbances containing alkylenediamine derivatives and packages containing such preparations
ZA961314B (en) Substituted benzenesulfonylureas and -thioreas processes for their preparation their use for the production of pharmaceutical preparations and medicaments containing them
GB8812621D0 (en) Pharmaceutical composition containing combination of analgesic agents
CS411491A3 (en) Nasal pharmaceutical composition and the application of octreotides
HUT42477A (en) Process for production of active substances decreasing blood-pressure and medical preparatives containing thereof

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930602